Ludger Klimek

Research interests

Publications

• Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

  Allergy · 2023 · https://doi.org/10.1111/all.15889

• Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet Respiratory Medicine · 2021 · 10.1016/s2213-2600(21)00097-7

• Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update

  Allergo Journal International · 2021 · 10.1007/s40629-020-00158-y

• The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries

  Current Allergy and Asthma Reports · 2020 · 10.1007/s11882-020-00961-1

• Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

  Clinical and Translational Allergy · 2020 · 10.1186/s13601-019-0303-6

• EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

  Journal of Allergy and Clinical Immunology · 2020 · https://doi.org/10.1016/j.jaci.2020.11.013

• Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement

  Allergy · 2020 · https://doi.org/10.1111/all.14302

• 2019 ARIA Care pathways for allergen immunotherapy

  Allergy · 2019 · 10.1111/all.13805

• Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

  Clinical and Translational Allergy · 2019 · https://doi.org/10.1186/s13601-019-0279-2

• Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

  Journal of Allergy and Clinical Immunology · 2019 · https://doi.org/10.1016/j.jaci.2019.06.049

• EAACI Position paper on the standardization of nasal allergen challenges

  Allergy · 2018 · https://doi.org/10.1111/all.13416

• Diagnosis and management of NSAID ‐Exacerbated Respiratory Disease (N‐ ERD )—a EAACI position paper

  Allergy · 2018 · https://doi.org/10.1111/all.13599

• Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

  Allergy · 2017 · https://doi.org/10.1111/all.13200

• Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

  Journal of Allergy and Clinical Immunology · 2017 · https://doi.org/10.1016/j.jaci.2017.03.050

• Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

  Journal of Allergy and Clinical Immunology · 2017 · https://doi.org/10.1016/j.jaci.2017.06.014

• Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care

  Allergo Journal International · 2017 · 10.1007/s40629-016-0006-7

• ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

  Clinical and Translational Allergy · 2016 · https://doi.org/10.1186/s13601-016-0137-4

• Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen‐induced rhinoconjunctivitis – an EAACI position paper

  Allergy · 2016 · 10.1111/all.13092

• Guideline for acute therapy and management of anaphylaxis

  Allergo Journal International · 2014 · 10.1007/s40629-014-0009-1

• Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

  Allergo Journal International · 2014 · https://doi.org/10.1007/s40629-014-0032-2

• Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

  Journal of Allergy and Clinical Immunology · 2009 · 10.1016/j.jaci.2008.10.044

• Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

  Allergy · 2008 · 10.1111/j.1398-9995.2008.01875.x

• Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: A controlled clinical trial

  Journal of Allergy and Clinical Immunology · 2004 · 10.1016/j.jaci.2003.12.589

• Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

  Journal of Allergy and Clinical Immunology · 2004 · 10.1016/j.jaci.2004.05.070

• Characteristics of Olfactory Disorders in Relation to Major Causes of Olfactory Loss

  Archives of Otolaryngology - Head and Neck Surgery · 2002 · 10.1001/archotol.128.6.635

• Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds

  European Archives of Oto-Rhino-Laryngology · 2000 · 10.1007/s004050050223

Current projects

No projects listed.